HistoWiz
YC W16New York City, US · Founded 2012 · New York corporation · 2 employees · 3 known investors
HistoWiz provides digital pathology services including precision histology, immunostaining, slide archiving, and AI-powered image analysis for research and clinical laboratories. The company serves biomedical researchers, pharmaceutical companies, and diagnostic labs with automated histology processing and pathology consultation.
Founders & leadership· Y Combinator alumni (W16)
KC
Ke ChenginFounder/CEO
LH

Linh HoangChief Executive Officer
JK

Jerry KuangChief Operations Officer
JF

Julie FeldsteinChief Pathologist
Investors · 3
Competitors · 8
by search overlapDiabetes Prevention Program87 shared keywords
ResearchGate67 shared keywords
Dervan et al50 shared keywords
Stagebio45 shared keywords
Abcam37 shared keywordsSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Cleveland Clinic, 202235 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Labcorp34 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Agilent24 shared keywords
Companies competing with HistoWiz for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$344.5KraisedJun 2016 · 9 investors · BiotechnologyRule 506(b)
▶$344.5KraisedJun 2016 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ke ChengExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $344.5K
- First sale
- Mar 2016
- Incorporated
- Corporation, New York, 2012
- Federal exemptions
- 06b
▶$1MraisedMar 2015 · 1 investors · Biotechnology
▶$1MraisedMar 2015 · 1 investors · Biotechnology
Officers, directors & promoters on the filing
- Ke ChengExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- Proceeds to insiders
- $40K
- First sale
- Feb 2015
- Incorporated
- Corporation, New York, 2012
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- HistoWiz Raises $32 Million in Series Athesaasnews.com · 2021
- HistoWiz Raises $32-Million Financing to Fully Automate Lab Operations, Launch New AI-Enabled Services & Establish a GLP Histopathology Lab in Miamidrug-dev.com · 2021
- HistoWiz Raises $32M in Series A Financingfinsmes.com · 2021